Back to results
US 11,166,995 B2Granted
Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor
AssigneesOsaka University, Genomidea Inc.
InventorsYasufumi Kaneda, Kazuma Sakura, Tomoyuki Nishikawa, Masanori Fukushima, Toshihiro Nakajima
Life of this patent
Estimating the term…
Abstract
The present invention provides an anticancer agent containing the following (1) and (2): (1) HVJ-E (hemagglutinating virus of Japan envelope), (2) an inhibitor of an immune checkpoint protein.
Claims6
A method for slowing the progression of melanoma, mesothelioma, or prostate cancer, comprising administering multiple doses of an effective amount of HVJ-E and anti-PD-1 antibody RMP1-14 to a subject, thereby slowing the progression of melanoma, mesothelioma, or prostate cancer in the subject.
Dependencies are inferred from the claim text.